These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67. Reflections on clinical expertise and silent know-how in voice therapy. Iwarsson J Logoped Phoniatr Vocol; 2015 Jul; 40(2):66-71. PubMed ID: 25110954 [TBL] [Abstract][Full Text] [Related]
68. Is more intensive better? Client and service provider outcomes for intensive versus standard therapy schedules for functional voice disorders. Wenke RJ; Stabler P; Walton C; Coman L; Lawrie M; O'Neill J; Theodoros D; Cardell E J Voice; 2014 Sep; 28(5):652.e31-652.e43. PubMed ID: 24929936 [TBL] [Abstract][Full Text] [Related]
69. Impact of laryngologist and speech pathologist coassessment on outcomes and billing revenue. Litts JK; Gartner-Schmidt JL; Clary MS; Gillespie AI Laryngoscope; 2015 Sep; 125(9):2139-42. PubMed ID: 26013916 [TBL] [Abstract][Full Text] [Related]
70. Feasibility of group voice therapy for individuals with Parkinson's disease. Searl J; Wilson K; Haring K; Dietsch A; Lyons K; Pahwa R J Commun Disord; 2011; 44(6):719-32. PubMed ID: 21889774 [TBL] [Abstract][Full Text] [Related]
71. A study of the effectiveness of voice therapy in the treatment of 45 patients with nonorganic dysphonia. Carding PN; Horsley IA; Docherty GJ J Voice; 1999 Mar; 13(1):72-104. PubMed ID: 10223677 [TBL] [Abstract][Full Text] [Related]
72. Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT): a pilot study. El Sharkawi A; Ramig L; Logemann JA; Pauloski BR; Rademaker AW; Smith CH; Pawlas A; Baum S; Werner C J Neurol Neurosurg Psychiatry; 2002 Jan; 72(1):31-6. PubMed ID: 11784821 [TBL] [Abstract][Full Text] [Related]
73. Voice Therapy Outcome: A Comparison Between Imitation Model Voice Therapy and Verbal Instructions Model Voice Therapy. Ohlsson AC; Li Y; Gustavsson I; Hofling K; Wahle U; Österlind C; Iwarsson J J Voice; 2024 Jul; 38(4):903-910. PubMed ID: 35227553 [TBL] [Abstract][Full Text] [Related]
74. Some guiding principles in emerging models of voice therapy for children. Verdolini Abbott K Semin Speech Lang; 2013 May; 34(2):80-93. PubMed ID: 23633172 [TBL] [Abstract][Full Text] [Related]
76. Long term outcome of psychogenic voice disorders. Reiter R; Rommel D; Brosch S Auris Nasus Larynx; 2013 Oct; 40(5):470-5. PubMed ID: 23414604 [TBL] [Abstract][Full Text] [Related]
77. Innovative technology for the assisted delivery of intensive voice treatment (LSVT®LOUD) for Parkinson disease. Halpern AE; Ramig LO; Matos CE; Petska-Cable JA; Spielman JL; Pogoda JM; Gilley PM; Sapir S; Bennett JK; McFarland DH Am J Speech Lang Pathol; 2012 Nov; 21(4):354-67. PubMed ID: 23071195 [TBL] [Abstract][Full Text] [Related]
78. [Functional disorders of the voice and their treatment (author's transl)]. Habermann G Arch Otorhinolaryngol; 1980; 227(1-2):171-345. PubMed ID: 7469925 [No Abstract] [Full Text] [Related]
79. The voice use reduction program. van der Merwe A Am J Speech Lang Pathol; 2004 Aug; 13(3):208-18. PubMed ID: 15339230 [TBL] [Abstract][Full Text] [Related]
80. Helping people to keep their voices healthy and to communicate effectively. Comins R Int J Lang Commun Disord; 1998; 33 Suppl():310-5. PubMed ID: 10343711 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]